BGM Group Ltd. (BGM): Total Assets
$433.81M
As of 2025-09-30
+88.7%
3-year compound annual growth
+55.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $433.81M | +718.5% | 2026-07-21, Balance as of period end |
| 2024-09-30 | $53.00M | +3.4% | 2026-07-21, Balance as of period end |
| 2023-09-30 | $51.26M | -20.6% | 2025-04-03, Balance as of period end |
| 2022-09-30 | $64.53M | -14.4% | 2024-02-15, Balance as of period end |
| 2021-09-30 | $75.35M | +56.5% | 2023-04-19, Balance as of period end |
| 2020-09-30 | $48.14M | +36.5% | 2022-10-13, Balance as of period end |
| 2019-09-30 | $35.27M | n/a | 2021-03-09, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BGM Group Ltd. (BGM) | 2025-09-30 | $433.81M | +718.5% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $19.27M | -59.5% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $30.08M | -1.6% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $8.97M | +26.9% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $47.13M | -12.9% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $28.56M | +29.2% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $638.50M | +81.3% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $154.69M | +117.6% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $76.82M | +1.6% |
Compare BGM, LIFD, SBFM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗